Premature Infants: Analysis of Serum Phosphate during the First 4 Weeks of Life

 

 Buy Article Permissions and Reprints

ABSTRACT

The purpose of this study was to establish phosphate norms for the first 4 weeks of life for neonates with birthweight (BW) 500 to 1500 g. The study group included 52 consecutively born neonates: group A (n = 24; BW 500 to 1000 g), and group B (n = 28; BW 1001 to 1500 g). Phosphate levels are reported daily (days 1 to 5), and then weekly until week 4. Except for the first 2 days of life, phosphate levels were statistically lower in group A versus group B. A prospective study is required to examine whether phosphate levels can be used as a marker of acuity in neonates and to examine the effect of phosphate repletion on metabolic functions.

REFERENCES

• 1 Bugg N C, Jones J A. Hypophosphataemia: pathophysiology, effects and management on the intensive care unit.  Anaesthesia. 1998;  53 895-902
  CrossrefPubMedGoogle Scholar
• 2 Knochel J P. The pathophysiology and clinical characteristics of severe hypophosphatemia.  Arch Intern Med. 1977;  137 203-220
  CrossrefPubMedGoogle Scholar
• 3 Brown G R, Greenwood J K. Drug and nutrition induced hypophosphatemia: mechanisms and relevance in the critically ill.  Ann Pharmacother. 1994;  28 626-632
  PubMedGoogle Scholar
• 4 Haglin L, Burman L A, Nilsson M. High prevalence of hypophosphatemia amongst patients with infectious diseases. A retrospective study.  J Intern Med. 1999;  246 45-52
  CrossrefPubMedGoogle Scholar
• 5 Craddock P R, Yawata Y, VanSanten L, Gilberstadt S, Silvis S, Jacob H S. Acquired phagocyte dysfunction: a complication of the hypophosphatemia of parenteral hyperalimention.  N Engl J Med. 1974;  290 1403-1407
  PubMedGoogle Scholar
• 6 Davis S V, Olichwier K K, Chakko S C. Reversible depression of myocardial performance in hypophosphatemia.  Am J Med Sci. 1988;  295 183-187
  PubMedGoogle Scholar
• 7 Bollaert P E, Levy B, Nace L, Laterre P F, Larcan A. Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock.  Chest. 1995;  107 1698-1701
  PubMedGoogle Scholar
• 8 Marick P E, Bedigian M K. Refeeding hypophosphatemia in critically ill patients in an intensive care unit: a prospective study.  Arch Surg. 1996;  131 1043-1047
  PubMedGoogle Scholar
• 9 Lichtman M A, Miller D R, Cohen J, Waterhouse C. Reduced red cell glycolysis, 2, 3-diphosphoglycerate and adenosine triphophate concentration, and increased hemoglobin-oxygen affinity caused by hypophatemia.  Ann Intern Med. 1971;  74 562-568
  PubMedGoogle Scholar
• 10 Zazzo J F, Troche G, Ruel P, Maintenant J. High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function.  Intensive Care Med. 1995;  21 826-831
  CrossrefPubMedGoogle Scholar
• 11 Barak V, Schwartz A, Kalickman I, Nisman B, Gurman G, Shoenfeld Y. Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines.  Am J Med. 1998;  104 40-47
  CrossrefPubMedGoogle Scholar
• 12 Daily W H, Tonnesen A S, Allen S J. Hypophosphatemia: incidence, etiology, and prevention in the trauma patient.  Crit Care Med. 1990;  18 1210-1214
  PubMedGoogle Scholar
• 13 Thomas J L, Reichelderfer T E. Premature infants: analysis of serum during the first seven weeks.  Clin Chem. 1968;  14 272-280
  PubMedGoogle Scholar

Dr. Laroia Nirupama

Department of Pediatrics, University of Rochester

601 Elmwood Avenue, Box 651, Rochester, NY 14642